-
1
-
-
25144513449
-
CSF biomarkers for Alzheimer's disease: Use in early diagnosis and evaluation of drug treatment
-
Blennow K (2005) CSF biomarkers for Alzheimer's disease: Use in early diagnosis and evaluation of drug treatment. Expert Rev Mol Diagn 5, 661-672.
-
(2005)
Expert Rev Mol Diagn
, vol.5
, pp. 661-672
-
-
Blennow, K.1
-
2
-
-
0035033619
-
Both total and phosphorylated tau are increased in Alzheimer's disease
-
Sjogren M, Davidsson P, Tullberg M, Minthon L, Wallin A, Wikkelso C, Granerus AK, Vanderstichele H, Vanmechelen E, Blennow K (2001) Both total and phosphorylated tau are increased in Alzheimer's disease. J Neurol Neurosurg Psychiatry 70, 624-630.
-
(2001)
J Neurol Neurosurg Psychiatry
, vol.70
, pp. 624-630
-
-
Sjogren, M.1
Davidsson, P.2
Tullberg, M.3
Minthon, L.4
Wallin, A.5
Wikkelso, C.6
Granerus, A.K.7
Vanderstichele, H.8
Vanmechelen, E.9
Blennow, K.10
-
3
-
-
0034487623
-
Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke
-
Hesse C, Rosengren L, Vanmechelen E, Vanderstichele H, Jensen C, Davidsson P, Blennow K (2000) Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke. J Alzheimers Dis 2, 199-206.
-
(2000)
J Alzheimers Dis
, vol.2
, pp. 199-206
-
-
Hesse, C.1
Rosengren, L.2
Vanmechelen, E.3
Vanderstichele, H.4
Jensen, C.5
Davidsson, P.6
Blennow, K.7
-
4
-
-
25144513449
-
CSF biomarkers for Alzheimer's disease: Use in early diagnosis and evaluation of drug treatment
-
Blennow K (2005) CSF biomarkers for Alzheimer's disease: Use in early diagnosis and evaluation of drug treatment. Expert Rev Mol Diagn 5, 661-672.
-
(2005)
Expert Rev Mol Diagn
, vol.5
, pp. 661-672
-
-
Blennow, K.1
-
5
-
-
33644832047
-
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans
-
Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, LaRossa GN, Spinner ML, Klunk WE, Mathis CA, DeKosky ST, Morris JC, Holtzman DM (2006) Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol 59, 512-519.
-
(2006)
Ann Neurol
, vol.59
, pp. 512-519
-
-
Fagan, A.M.1
Mintun, M.A.2
MacH, R.H.3
Lee, S.Y.4
Dence, C.S.5
Shah, A.R.6
Larossa, G.N.7
Spinner, M.L.8
Klunk, W.E.9
Mathis, C.A.10
Dekosky, S.T.11
Morris, J.C.12
Holtzman, D.M.13
-
6
-
-
0037465449
-
CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
-
Strozyk D, Blennow K, White LR, Launer LJ (2003) CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 60, 652-656.
-
(2003)
Neurology
, vol.60
, pp. 652-656
-
-
Strozyk, D.1
Blennow, K.2
White, L.R.3
Launer, L.J.4
-
7
-
-
33645775230
-
Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry
-
Portelius E, Westman-Brinkmalm A, Zetterberg H, Blennow K (2006) Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry. J Proteome Res 5, 1010-1016.
-
(2006)
J Proteome Res
, vol.5
, pp. 1010-1016
-
-
Portelius, E.1
Westman-Brinkmalm, A.2
Zetterberg, H.3
Blennow, K.4
-
8
-
-
84856385819
-
Stability of amyloid-beta peptides in plasma and serum
-
Bibl M, Welge V, Esselmann H, Wiltfang J (2012) Stability of amyloid-beta peptides in plasma and serum. Electrophoresis 33, 445-450.
-
(2012)
Electrophoresis
, vol.33
, pp. 445-450
-
-
Bibl, M.1
Welge, V.2
Esselmann, H.3
Wiltfang, J.4
-
9
-
-
33847105164
-
Dominance of amyloid precursor protein sequence over host cell secretases in determining betaamyloid profiles studies of interspecies variation and drug action by internally standardized immunoprecipitation/mass spectrometry
-
Du P, Wood KM, Rosner MH, Cunningham D, Tate B, Geoghegan KF (2007) Dominance of amyloid precursor protein sequence over host cell secretases in determining betaamyloid profiles studies of interspecies variation and drug action by internally standardized immunoprecipitation/mass spectrometry. J Pharmacol Exp Ther 320, 1144-1152.
-
(2007)
J Pharmacol Exp Ther
, vol.320
, pp. 1144-1152
-
-
Du, P.1
Wood, K.M.2
Rosner, M.H.3
Cunningham, D.4
Tate, B.5
Geoghegan, K.F.6
-
10
-
-
0033975534
-
The choroid plexuses and the barriers between the blood and the cerebrospinal fluid
-
Segal MB (2000) The choroid plexuses and the barriers between the blood and the cerebrospinal fluid. Cell Mol Neurobiol 20, 183-196.
-
(2000)
Cell Mol Neurobiol
, vol.20
, pp. 183-196
-
-
Segal, M.B.1
-
11
-
-
59349088328
-
Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis
-
Gresle MM, Shaw G, Jarrot B, Alexandrou EN, Friedhuber A, Kilpatrick TJ, Butzkueven H (2008) Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis. J Neurosci Res 86, 3548-3555.
-
(2008)
J Neurosci Res
, vol.86
, pp. 3548-3555
-
-
Gresle, M.M.1
Shaw, G.2
Jarrot, B.3
Alexandrou, E.N.4
Friedhuber, A.5
Kilpatrick, T.J.6
Butzkueven, H.7
-
12
-
-
0142071146
-
A specific ELISA for measuring neurofilament heavy chain phosphoforms
-
Petzold A, Keir G, Green AJ, Giovannoni G, Thompson EJ (2003) A specific ELISA for measuring neurofilament heavy chain phosphoforms. J Immunol Methods 278, 179-190.
-
(2003)
J Immunol Methods
, vol.278
, pp. 179-190
-
-
Petzold, A.1
Keir, G.2
Green, A.J.3
Giovannoni, G.4
Thompson, E.J.5
-
14
-
-
33646707066
-
The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer's disease
-
Brettschneider J, Petzold A, Schottle D, Claus A, Riepe M, Tumani H (2006) The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer's disease. Dement Geriatr Cogn Disord 21, 291-295.
-
(2006)
Dement Geriatr Cogn Disord
, vol.21
, pp. 291-295
-
-
Brettschneider, J.1
Petzold, A.2
Schottle, D.3
Claus, A.4
Riepe, M.5
Tumani, H.6
-
15
-
-
0037040525
-
Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients
-
Hu YY, He SS, Wang XC, Duan QH, Khatoon S, Iqbal K, Grundke-Iqbal I, Wang JZ (2002) Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients. Neurosci Lett 320, 156-160.
-
(2002)
Neurosci Lett
, vol.320
, pp. 156-160
-
-
Hu, Y.Y.1
He, S.S.2
Wang, X.C.3
Duan, Q.H.4
Khatoon, S.5
Iqbal, K.6
Grundke-Iqbal, I.7
Wang, J.Z.8
-
16
-
-
0033596812
-
Neurofilament protein levels in CSF are increased in dementia
-
Rosengren LE, Karlsson JE, Sjogren M, Blennow K, Wallin A (1999) Neurofilament protein levels in CSF are increased in dementia. Neurology 52, 1090-1093.
-
(1999)
Neurology
, vol.52
, pp. 1090-1093
-
-
Rosengren, L.E.1
Karlsson, J.E.2
Sjogren, M.3
Blennow, K.4
Wallin, A.5
-
18
-
-
0021271971
-
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
-
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
-
(1984)
Neurology
, vol.34
, pp. 939-944
-
-
McKhann, G.1
Drachman, D.2
Folstein, M.3
Katzman, R.4
Price, D.5
Stadlan, E.M.6
-
19
-
-
0016823810
-
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician
-
Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
-
(1975)
J Psychiatr Res
, vol.12
, pp. 189-198
-
-
Folstein, M.F.1
Folstein, S.E.2
McHugh, P.R.3
-
20
-
-
0024246154
-
Alzheimer's Disease Assessment Scale (ADAS
-
Mohs RC, Cohen L (1988) Alzheimer's Disease Assessment Scale (ADAS). Psychopharmacol Bull 24, 627-628.
-
(1988)
Psychopharmacol Bull
, vol.24
, pp. 627-628
-
-
Mohs, R.C.1
Cohen, L.2
-
21
-
-
0033637408
-
Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma
-
Vanderstichele H, Van Kerschaver E, Hesse C, Davidsson P, Buyse MA, Andreasen N, Minthon L, Wallin A, Blennow K, Vanmechelen E (2000) Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma. Amyloid 7, 245-258.
-
(2000)
Amyloid
, vol.7
, pp. 245-258
-
-
Vanderstichele, H.1
Van Kerschaver, E.2
Hesse, C.3
Davidsson, P.4
Buyse, M.A.5
Andreasen, N.6
Minthon, L.7
Wallin, A.8
Blennow, K.9
Vanmechelen, E.10
-
22
-
-
0023111174
-
Varying degrees of phosphorylation determine microheterogeneity of the heavy neurofilament polypeptide (Nf-H
-
Goldstein ME, Sternberger LA, Sternberger NH (1987) Varying degrees of phosphorylation determine microheterogeneity of the heavy neurofilament polypeptide (Nf-H). J Neuroimmunol 14, 135-148.
-
(1987)
J Neuroimmunol
, vol.14
, pp. 135-148
-
-
Goldstein, M.E.1
Sternberger, L.A.2
Sternberger, N.H.3
-
23
-
-
34247893817
-
Longitudinal stability of CSF biomarkers in Alzheimer's disease
-
Blennow K, Zetterberg H, Minthon L, Lannfelt L, Strid S, Annas P, Basun H, Andreasen N(2007) Longitudinal stability of CSF biomarkers in Alzheimer's disease. Neurosci Lett 419, 18-22.
-
(2007)
Neurosci Lett
, vol.419
, pp. 18-22
-
-
Blennow, K.1
Zetterberg, H.2
Minthon, L.3
Lannfelt, L.4
Strid, S.5
Annas, P.6
Basun, H.7
Andreasen, N.8
-
24
-
-
12144290725
-
Plasma levels of betaamyloid( 1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins
-
Hoglund K, Wiklund O, Vanderstichele H, Eikenberg O, Vanmechelen E, Blennow K (2004) Plasma levels of betaamyloid( 1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins. Arch Neurol 61, 333-337.
-
(2004)
Arch Neurol
, vol.61
, pp. 333-337
-
-
Hoglund, K.1
Wiklund, O.2
Vanderstichele, H.3
Eikenberg, O.4
Vanmechelen, E.5
Blennow, K.6
-
25
-
-
20844457621
-
The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease
-
Hoglund K, Thelen KM, Syversen S, Sjogren M, von Bergmann K, Wallin A, Vanmechelen E, Vanderstichele H, Lutjohann D, Blennow K (2005) The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 19, 256-265.
-
(2005)
Dement Geriatr Cogn Disord
, vol.19
, pp. 256-265
-
-
Hoglund, K.1
Thelen, K.M.2
Syversen, S.3
Sjogren, M.4
Von Bergmann, K.5
Wallin, A.6
Vanmechelen, E.7
Vanderstichele, H.8
Lutjohann, D.9
Blennow, K.10
-
26
-
-
14444269228
-
Longitudinal study of cerebrospinal fluid levels of tau A beta1-40, and A beta1-42(43) in Alzheimer's disease: A study in Japan
-
Kanai M, Matsubara E, Isoe K, Urakami K, Nakashima K, Arai H, Sasaki H, Abe K, Iwatsubo T, Kosaka T, Watanabe M, Tomidokoro Y, Shizuka M, Mizushima K, Nakamura T, Igeta Y, Ikeda Y, Amari M, Kawarabayashi T, Ishiguro K, Harigaya Y, Wakabayashi K, Okamoto K, Hirai S, Shoji M (1998) Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: A study in Japan. Ann Neurol 44, 17-26.
-
(1998)
Ann Neurol
, vol.44
, pp. 17-26
-
-
Kanai, M.1
Matsubara, E.2
Isoe, K.3
Urakami, K.4
Nakashima, K.5
Arai, H.6
Sasaki, H.7
Abe, K.8
Iwatsubo, T.9
Kosaka, T.10
Watanabe, M.11
Tomidokoro, Y.12
Shizuka, M.13
Mizushima, K.14
Nakamura, T.15
Igeta, Y.16
Ikeda, Y.17
Amari, M.18
Kawarabayashi, T.19
Ishiguro, K.20
Harigaya, Y.21
Wakabayashi, K.22
Okamoto, K.23
Hirai, S.24
Shoji, M.25
more..
-
27
-
-
0033953722
-
Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease
-
Tapiola T, Pirttila T, Mikkonen M, Mehta PD, Alafuzoff I, Koivisto K, Soininen H (2000) Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease. Neurosci Lett 280, 119-122.
-
(2000)
Neurosci Lett
, vol.280
, pp. 119-122
-
-
Tapiola, T.1
Pirttila, T.2
Mikkonen, M.3
Mehta, P.D.4
Alafuzoff, I.5
Koivisto, K.6
Soininen, H.7
-
28
-
-
77949423619
-
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
-
Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6, 131-144.
-
(2010)
Nat Rev Neurol
, vol.6
, pp. 131-144
-
-
Blennow, K.1
Hampel, H.2
Weiner, M.3
Zetterberg, H.4
-
29
-
-
80052795071
-
Long-term stability of Alzheimer's disease biomarker proteins in cerebrospinal fluid
-
Schipke CG, Jessen F, Teipel S, Luckhaus C, Wiltfang J, Esselmann H, Frolich L, Maier W, Ruther E, Heppner FL, Prokop S, Heuser I, Peters O (2011) Long-term stability of Alzheimer's disease biomarker proteins in cerebrospinal fluid. J Alzheimers Dis 26, 255-262.
-
(2011)
J Alzheimers Dis
, vol.26
, pp. 255-262
-
-
Schipke, C.G.1
Jessen, F.2
Teipel, S.3
Luckhaus, C.4
Wiltfang, J.5
Esselmann, H.6
Frolich, L.7
Maier, W.8
Ruther, E.9
Heppner, F.L.10
Prokop, S.11
Heuser, I.12
Peters, O.13
-
30
-
-
0033987298
-
Levels of alpha-and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients
-
Sennvik K, Fastbom J, Blomberg M, Wahlund LO, Winblad B, Benedikz E (2000) Levels of alpha-and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett 278, 169-172.
-
(2000)
Neurosci Lett
, vol.278
, pp. 169-172
-
-
Sennvik, K.1
Fastbom, J.2
Blomberg, M.3
Wahlund, L.O.4
Winblad, B.5
Benedikz, E.6
-
31
-
-
0041886881
-
Measurement of alpha-and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients
-
Olsson A, Hoglund K, Sjogren M, Andreasen N, Minthon L, Lannfelt L, Buerger K, Moller HJ, Hampel H, Davidsson P, Blennow K (2003) Measurement of alpha-and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients. Exp Neurol 183, 74-80.
-
(2003)
Exp Neurol
, vol.183
, pp. 74-80
-
-
Olsson, A.1
Hoglund, K.2
Sjogren, M.3
Andreasen, N.4
Minthon, L.5
Lannfelt, L.6
Buerger, K.7
Moller, H.J.8
Hampel, H.9
Davidsson, P.10
Blennow, K.11
-
32
-
-
75549090428
-
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: A multicenter study
-
Lewczuk P, Kamrowski-Kruck H, Peters O, Heuser I, Jessen F, Popp J, Burger K, Hampel H, Frolich L, Wolf S, Prinz B, Jahn H, Luckhaus C, Perneczky R, Hull M, Schroder J, Kessler H, Pantel J, Gertz HJ, Klafki HW, Kolsch H, Reulbach U, Esselmann H, Maler JM, Bibl M, Kornhuber J, Wiltfang J (2010) Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: A multicenter study. Mol Psychiatry 15, 138-145.
-
(2010)
Mol Psychiatry
, vol.15
, pp. 138-145
-
-
Lewczuk, P.1
Kamrowski-Kruck, H.2
Peters, O.3
Heuser, I.4
Jessen, F.5
Popp, J.6
Burger, K.7
Hampel, H.8
Frolich, L.9
Wolf, S.10
Prinz, B.11
Jahn, H.12
Luckhaus, C.13
Perneczky, R.14
Hull, M.15
Schroder, J.16
Kessler, H.17
Pantel, J.18
Gertz, H.J.19
Klafki, H.W.20
Kolsch, H.21
Reulbach, U.22
Esselmann, H.23
Maler, J.M.24
Bibl, M.25
Kornhuber, J.26
Wiltfang, J.27
more..
-
33
-
-
0029379605
-
Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease
-
Checler F (1995) Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease. J Neurochem 65, 1431-1444.
-
(1995)
J Neurochem
, vol.65
, pp. 1431-1444
-
-
Checler, F.1
-
34
-
-
0032563098
-
Abasic amino acid in the cytoplasmic domain of Alzheimer's beta-amyloid precursor protein (APP) is essential for cleavage ofAPPat the alpha-site
-
Tomita S, Kirino Y, Suzuki T (1998)Abasic amino acid in the cytoplasmic domain of Alzheimer's beta-amyloid precursor protein (APP) is essential for cleavage ofAPPat the alpha-site. J Biol Chem 273, 19304-19310.
-
(1998)
J Biol Chem
, vol.273
, pp. 19304-19310
-
-
Tomita, S.1
Kirino, Y.2
Suzuki, T.3
-
35
-
-
0032960305
-
Regulation of amyloid precursor protein cleavage
-
Mills J, Reiner PB (1999) Regulation of amyloid precursor protein cleavage. J Neurochem 72, 443-460.
-
(1999)
J Neurochem
, vol.72
, pp. 443-460
-
-
Mills, J.1
Reiner, P.B.2
-
36
-
-
33645800776
-
Axonal damage markers in cerebrospinal fluid are increased in ALS
-
Brettschneider J, Petzold A, Sussmuth SD, Ludolph AC, Tumani H (2006) Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology 66, 852-856.
-
(2006)
Neurology
, vol.66
, pp. 852-856
-
-
Brettschneider, J.1
Petzold, A.2
Sussmuth, S.D.3
Ludolph, A.C.4
Tumani, H.5
-
37
-
-
33947710043
-
CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls
-
Pijnenburg YA, Janssen JC, Schoonenboom NS, Petzold A, Mulder C, Stigbrand T, Norgren N, Heijst H, Hack CE, Scheltens P, Teunissen CE (2007) CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls. Dement Geriatr Cogn Disord 23, 225-230.
-
(2007)
Dement Geriatr Cogn Disord
, vol.23
, pp. 225-230
-
-
Pijnenburg, Y.A.1
Janssen, J.C.2
Schoonenboom, N.S.3
Petzold, A.4
Mulder, C.5
Stigbrand, T.6
Norgren, N.7
Heijst, H.8
Hack, C.E.9
Scheltens, P.10
Teunissen, C.E.11
-
38
-
-
0343091321
-
Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
-
Sjogren M, Rosengren L, Minthon L, Davidsson P, Blennow K, Wallin A (2000) Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD. Neurology 54, 1960-1964.
-
(2000)
Neurology
, vol.54
, pp. 1960-1964
-
-
Sjogren, M.1
Rosengren, L.2
Minthon, L.3
Davidsson, P.4
Blennow, K.5
Wallin, A.6
-
39
-
-
0025246218
-
Cognitive deterioration in Alzheimer's disease: Behavioral and health factors
-
Teri L, Hughes JP, Larson EB (1990) Cognitive deterioration in Alzheimer's disease: Behavioral and health factors. J Gerontol 45, P58-P63.
-
(1990)
J Gerontol
, vol.45
-
-
Teri, L.1
Hughes, J.P.2
Larson, E.B.3
-
40
-
-
0024246154
-
Alzheimer's Disease Assessment Scale (ADAS
-
Mohs RC, Cohen L (1988) Alzheimer's Disease Assessment Scale (ADAS). Psychopharmacol Bull 24, 627-628.
-
(1988)
Psychopharmacol Bull
, vol.24
, pp. 627-628
-
-
Mohs, R.C.1
Cohen, L.2
-
41
-
-
0012895842
-
-
4th ed SAS Institute Inc., Cary, NC
-
Littell, RC, Stroup WW, Freund RJ (2002) SAS for Linear Models, 4th ed., SAS Institute, Inc., Cary, NC.
-
(2002)
SAS for Linear Models
-
-
Littell, R.C.1
Stroup, W.W.2
Freund, R.J.3
|